Post reply

The message has the following error or errors that must be corrected before continuing:
Warning: this topic has not been posted in for at least 365 days.
Unless you're sure you want to reply, please consider starting a new topic.
Other options
Verification:
Please leave this box empty:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
Spell the answer to 6 + 7 =:
Three blonde, blue-eyed siblings are named Suzy, Jack and Bill.  What color hair does the sister have?:
Shortcuts: ALT+S post or ALT+P preview

Topic summary

Posted by spacecanada
 - November 10, 2019, 05:06:21 PM
My question has been answered... well, sort of.

https://www.prnewswire.com/news-releases/bryn-pharma-research-on-epinephrine-nasal-spray-presented-at-the-american-college-of-allergy-asthma-and-immunology-annual-meeting-300955162.html

Apparently congestion makes the nasal epinephrine more effective?  Someone please explain this to me better than the article above.  What about a gushing runny nose?  or sneezing? 

I'm not sure I would rely on it as a first measure, as I think IM may still be needed in some cases.  Still, more options are a good thing.  Great, even, if they work in a practical setting.
Posted by spacecanada
 - December 11, 2017, 05:25:08 PM
I have to wonder how well a nasal spray would work with nasal symptoms being part of a reaction.  Think of a really snotty reaction; I don't think a spray could be effective then, or when you have congestion from other conditions such as viruses.  It will be interesting to see how the trial considers those factors. (They are spraying allergens in the nose and seeing how it affects the epinephrine.)

Sounds like an interesting experiment, for sure. 
Posted by PurpleCat
 - December 11, 2017, 04:54:03 PM
Exciting!
Posted by Macabre
 - December 11, 2017, 01:23:53 PM
https://snacksafely.com/2017/12/phase-i-trial-of-epinephrine-nasal-spray-for-anaphylaxis-begins/

Quote
INSYS Therapeutics announced Thursday that it has begun a proof-of-concept study of two formulations of epinephrine nasal spray for the treatment of anaphylaxis with the enrollment of the first patient.

This Phase I clinical trial is designed to establish whether intranasal administration of epinephrine is bioequivalent to the standard method of delivering the drug via intramuscular injection. . . . .